Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 2, 2018

Conditions
Normal Tension Glaucoma
Interventions
DRUG

PHP-201 0.25% ophthalmic solution

3 drops daily, 28 days

DRUG

PHP-201 0.5% ophthalmic solution

3 drops daily, 28 days

DRUG

Placebo ophthalmic solution

3 drops daily, 28 days

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

pH Pharma

INDUSTRY